Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 4/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | MPI | P34949 | 1/20 | 0.41 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.41 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | MYC | P01106 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10133971 | 0.87 | CYP2A6 (0.38) | CYP2A6CYP1A2ALDH1A1HPGDCASP1 | |
| SCHEMBL474136 | 0.78 | POLB (0.46) | ALDH1A1HPGDCASP1MPICACNA1B | |
| SCHEMBL2877910 | 0.78 | — | — | |
| SCHEMBL29699888 | 0.78 | POLB (0.46) | ALDH1A1HPGDCASP1MPICACNA1B | |
| SCHEMBL9917545 | 0.74 | CES1 (0.50) | CYP1A2ALDH1A1SMN1; SMN2MAPK1MEN1 | |
| SCHEMBL10133951 | 0.73 | CYP3A4 (0.35) | CYP1A2ALDH1A1HPGDSMN1; SMN2MAPK1 | |
| SCHEMBL12235642 | 0.73 | CYP1B1 (0.63) | ALDH1A1HPGDCASP1MPICACNA1B | |
| SCHEMBL23337524 | 0.73 | ALDH1A1 (0.38) | CYP1A2ALDH1A1HPGDCASP1MPI | |
| SCHEMBL7263146 | 0.72 | MEN1 (0.40) | ALDH1A1HPGDCASP1MPICACNA1B | |
| SCHEMBL2330603 | 0.70 | MAOA (0.44) | CYP2A6CYP1A2ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120146009-A1 | NOVEL COMPOUND, FIELD-EFFECTIVE TRANSISTOR, SOLAR CELL, METHOD FOR PRODUCING SAID COMPOUND, FIELD-EFFECTIVE TRANSISTOR, AND SOLAR CELL, COMPOSITION FOR ORGANIC SEMICONDUCTOR LAYER, AND COMPOSITION FOR P-TYPE SEMICONDUCTOR LAYER | SHARP KABUSHIKI KAISHA (JP) | 2012-06-14 | — | — | US | disclosed |
| US-20120146009-A1 | NOVEL COMPOUND, FIELD-EFFECTIVE TRANSISTOR, SOLAR CELL, METHOD FOR PRODUCING SAID COMPOUND, FIELD-EFFECTIVE TRANSISTOR, AND SOLAR CELL, COMPOSITION FOR ORGANIC SEMICONDUCTOR LAYER, AND COMPOSITION FOR P-TYPE SEMICONDUCTOR LAYER | SHARP KABUSHIKI KAISHA (JP) | 2012-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120146009-A1 | NOVEL COMPOUND, FIELD-EFFECTIVE TRANSISTOR, SOLAR CELL, METHOD FOR PRODUCING SAID COMPOUND, FIELD-EFFECTIVE TRANSISTOR, AND SOLAR CELL, COMPOSITION FOR ORGANIC SEMICONDUCTOR LAYER, AND COMPOSITION FOR P-TYPE SEMICONDUCTOR LAYER | CRY1, TCF4, H1-4 | CYP2A6 1107/4885CYP1A2 760/4885ALDH1A1 2977/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.